Advanced Search

 

Study ID Status Title Patient Level Data
49653/114 Completed An Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Efficacy of Rosiglitazone When Administered Once or Twice Daily in Combination with Insulin to Patients with Type 2 Diabetes Study Listed on ClinicalStudyDataRequest.com
49653/131 Completed A Double-blind, Placebo-controlled, Parallel-group Study to Determine the Effect of BRL- 49653C Rosiglitazone, on Fat Distribution When Administered for 26 Weeks to Subjects With Impaired Glucose Tolerance (IGT) Study Listed on ClinicalStudyDataRequest.com
49653/135 Completed 2-year, Randomized, Double-blind, Parallel Group Study to Compare the Efficacy, Safety and Tolerability of Rosiglitazone Versus Placebo in Combination with Glipizide in Elderly Patients with Type 2 Diabetes Mellitus who are Inadequately Controlled on Glipizide Therapy Study Listed on ClinicalStudyDataRequest.com
49653/136 Completed A 26-week Randomised, Double-Blind, Multicentre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Rosiglitazone with Concurrent Insulin Therapy and/or a Sulphonylurea in Type 2 Diabetic Patients with Chronic Renal Failure (Not on Dialysis). Study Listed on ClinicalStudyDataRequest.com
49653/140 Completed A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Effects of Rosiglitazone on Post Prandial Glycaemia in Type 2 Diabetic Patients. Study Listed on ClinicalStudyDataRequest.com
49653/143 Completed A 24-Week Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of AVANDIA (8mg once daily) in Combination with Glyburide in African American and Hispanic Patients with Type 2 Diabetes Mellitus who are Inadequately Controlled on Glyburide Monotherapy Study Listed on ClinicalStudyDataRequest.com
49653/183 Completed A 24 Week Randomized, Double-blind, Double-dummy, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of Avandia™ XR and AVANDIA™ (4mg BD) in Patients with Type 2 Diabetes Study Listed on ClinicalStudyDataRequest.com
49653/207 Completed A 24-week Randomized, Double-blind, Active-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rosiglitazone When Administered to Pediatric Patients with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
49653/211 Completed A 52-week double-blind study of the effect of rosiglitazone on cardiovascular structure and function in subjects with type 2 diabetes mellitus and congestive heart failure (NYHA class I/II) Study Listed on ClinicalStudyDataRequest.com
49653/224 Completed A Study to Examine the Effects of Alucol® , a Combination Magnesium/Aluminum Hydroxide-Containing Antacid, on the Pharmacokinetics of Rosiglitazone (8 mg). Study Listed on ClinicalStudyDataRequest.com
49653/225 Completed A Double-Blind Study to Assess the Effect of Rosiglitazone (RSG) on the Pharmacodynamics and Pharmacokinetics of Acenocoumerol in Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
49653/231_4yrfollowup Completed Observational Follow up of RECORD: Rosiglitazone evaluated for cardiac outcomes and regulation of glycaemia in diabetes. A long-term, open-label, randomised study in patients with type 2 diabetes mellitus, comparing the combination of rosiglitazone and eit
49653/270 Completed A Bioequivalence Study With a Combination Tablet Formulation of Rosiglitazone and Metformin (4 mg/500 mg) Compared to Concomitant Dosing of Rosiglitazone 4 mg and Metformin 500 mg Commercial Tablets-and a Dose Proportionality Study Comparing the 4 mg/500 mg and 1 mg/500 mg Combination Formulations. Study Listed on ClinicalStudyDataRequest.com
49653/271 Completed A Study to Assess the Effect of Food on the Pharmacokinetics of a Rosiglitazone 4mg and Metformin 500mg Combination Tablet Formulation and a Study Comparing the Pharmacokinetics of Rosiglitazone 4mg and Metformin 500mg Combination Tablet to Concomitant Dosing of Rosiglitazone 4mg and Metformin 500mg Commercial Tablets in the Fed State in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
49653/282 Completed A Double-Blind Feasibility Study to Estimate and Compare the Effect of Rosiglitazone in Parallel with Glyburide on Cognition in Patients with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
49653/284 Completed A 24-Week Randomized, Double-blind, Double-Dummy, Multicenter Study to Compare the Efficacy of AVANDIA when added to Submaximal Doses of Metformin and to Compare the Tolerability of the Combination to Metformin Monotherapy when Administered to Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
49653/292 Completed A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Three Dose Levels of Rosiglitazone Maleate in the Treatment of Moderate to Severe Plaque Psoriasis. Study Listed on ClinicalStudyDataRequest.com
49653/299 Completed A single dose study to assess the tolerability and food effect of an enterically-coated formulation of the commercial immediate release tablet of rosiglitazone and an enterically-coated modified release tablet formulation of rosiglitazone in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
49653/300 Completed A Bioequivalence Study Comparing Tablets Manufactured with the 8 mg Anhydrate Form IV (ANF4) to the Commercial Anhydrate Form I (ANF1) of Rosiglitazone Maleate. Study Listed on ClinicalStudyDataRequest.com
49653/301 Completed A Study to Evaluate the Effect of Food on the Pharmacokinetics of a Modified Release Formulation of Rosiglitazone 8 mg in Healthy Volunteers After Repeat Dosing. Study Listed on ClinicalStudyDataRequest.com
49653/309 Completed A study to evaluate the pharmacokinetics of eight prototype formulations of rosiglitazone 8 mg in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
49653/311 Completed A 12-Week, Randomized, Double-blind Study to Evaluate the Effects of Rosiglitazone 4 mg BD and Rosiglitazone 4 mg QD on Lipids in Type 2 Diabetes Mellitus Subjects Taking Statins Study Listed on ClinicalStudyDataRequest.com
49653/325 Completed A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Control, Clinical Evaluation of Rosiglitazone in Combination with Glimepiride Compared to Glimepiride Plus Placebo for 24 Weeks in Subjects with Type 2 DiabetesMellitus Who are Inadequately Controlled on Non-TZD Oral Monotherapy Study Listed on ClinicalStudyDataRequest.com
49653/326 Active, not recruiting A 24-week Randomized, Double-Blind, Parallel-Group, Multicenter Study to Demonstrate the Efficacy and Safety of Two Different Rosiglitazone Dosing Regimens, 4mg OD and 8mg OD, in Poorly-Controlled Drug Naive Patients with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
49653/330 Completed A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Assess the Safety and Efficacy of Three Dose Levels of Rosiglitazone Maleate in the Treatment of Chronic Plaque Psoriasis Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.